Dr. Tse Wen Chang obtained his B.Sc. (1970) and M.Sc. (1972) degrees from the Department of Chemistry, National Tsing Hua University in Taiwan.  He did his Ph.D. thesis work with Dr. Alfred L. Goldberg at the Department of Cell & Developmental Biology, Harvard University (Ph.D., 1977) and postdoctoral work with Dr. Herman N. Eisen in the Center for Cancer Research, M.I.T. (1977-80).  In 1980, he joined the newly formed Immunobiology Division in Ortho Pharmaceutical Corporation (a subsidiary of Johnson & Johnson) and worked on OKT3 monoclonal antibody.  Subsequently, he moved to the newly founded Centocor, Inc. as Director of Immunology Research in 1981 and as Vice President of Research in 1984.  In 1986, he was recruited by Baylor College of Medicine in Houston and was appointed full professor in the Department of Molecular Virology.  In the same year, he and Dr. Nancy T. Chang founded Tanox, Inc., where Dr. Chang served as the Vice President of R&D from 1986 to 1996, and as a director of the board from 1986 until Genentech acquired Tanox in 2007.

Immunolog,  Chemistry